Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3927]

GORTEC: Cisplatin chemoradiation plus debio 1143 in patients with locally...

Prof Jean Bourhis - Lausanne University Hospital, Lausanne, Switzerland

GORTEC: Cisplatin chemoradiation plus debio 1143 in patients with locally advanced head and neck squamous cell carcinoma ( Prof Jean Bourhis - Lausanne University Hospital, Lausanne, Switzerland )

Shaping the future of metastasis - ecancer investigates

Monique Biryiana - ecancer Medical Reporter, Dr Chris Bakal - Dynamical Cell...

Shaping the future of metastasis - ecancer investigates ( Monique Biryiana - ecancer Medical Reporter, Dr Chris Bakal - Dynamical Cell Systems Team Leader, Patricia Pascual Vargas - PhD Student )

Comment: Supporting a sustainable biosimilar solution

Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands

Comment: Supporting a sustainable biosimilar solution ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )

Comment: Critical quality attributes of biosimilars

Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands

Comment: Critical quality attributes of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )

Simplifying molecular subtypes of metastatic gastric cancer

Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain

Simplifying molecular subtypes of metastatic gastric cancer ( Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain )

Quality of life results from pembrolizumab vs chemotherapy in gastric or...

Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain

Quality of life results from pembrolizumab vs chemotherapy in gastric or gastroesophageal junction cancer ( Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain )

TROPHY-U-01: Sacituzumab govitecan in patients with mUC after failure of...

Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA

TROPHY-U-01: Sacituzumab govitecan in patients with mUC after failure of platinum-based regimens or immunotherapy ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )

Highlights from ESMO 2019

Prof Josep Tabernero - ESMO President

Highlights from ESMO 2019 ( Prof Josep Tabernero - ESMO President )

SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal...

Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA

SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal cancer patients during the dose escalation phase ( Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA )

Nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC

Prof Ahmed Kaseb - MD Anderson Cancer Center, Houston, USA

Nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC ( Prof Ahmed Kaseb - MD Anderson Cancer Center, Houston, USA )

Association between tTMB and clinical outcomes with pembrolizumab alone in PD...

Prof Roy Herbst - Yale Cancer Center, New Haven, USA

Association between tTMB and clinical outcomes with pembrolizumab alone in PD-L1-positive advanced NSCLC in KEYNOTE-010 and -042 ( Prof Roy Herbst - Yale Cancer Center, New Haven, USA )

IMPALA results: Lefitolimod vs standard of care in metastatic colorectal cancer

Dr Ramon Salazar - Catalan Institute of Oncology, Barcelona, Spain

IMPALA results: Lefitolimod vs standard of care in metastatic colorectal cancer ( Dr Ramon Salazar - Catalan Institute of Oncology, Barcelona, Spain )

More from ecancer